rs113208290

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_030665.4(RAI1):​c.1142C>T​(p.Ala381Val) variant causes a missense change. The variant allele was found at a frequency of 0.00445 in 1,614,076 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0040 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0045 ( 28 hom. )

Consequence

RAI1
NM_030665.4 missense

Scores

1
6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 3.90
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007868499).
BP6
Variant 17-17794090-C-T is Benign according to our data. Variant chr17-17794090-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 96177.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17794090-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.004 (609/152324) while in subpopulation AMR AF= 0.00811 (124/15296). AF 95% confidence interval is 0.00695. There are 2 homozygotes in gnomad4. There are 289 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 609 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RAI1NM_030665.4 linkuse as main transcriptc.1142C>T p.Ala381Val missense_variant 3/6 ENST00000353383.6 NP_109590.3 Q7Z5J4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RAI1ENST00000353383.6 linkuse as main transcriptc.1142C>T p.Ala381Val missense_variant 3/61 NM_030665.4 ENSP00000323074.4 Q7Z5J4-1
RAI1ENST00000395774.1 linkuse as main transcriptc.1142C>T p.Ala381Val missense_variant 2/22 ENSP00000379120.1 A8MXE8

Frequencies

GnomAD3 genomes
AF:
0.00400
AC:
609
AN:
152206
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00812
Gnomad ASJ
AF:
0.0138
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00517
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00382
AC:
959
AN:
251210
Hom.:
2
AF XY:
0.00378
AC XY:
513
AN XY:
135794
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00460
Gnomad ASJ exome
AF:
0.0136
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000588
Gnomad FIN exome
AF:
0.000786
Gnomad NFE exome
AF:
0.00501
Gnomad OTH exome
AF:
0.00604
GnomAD4 exome
AF:
0.00449
AC:
6569
AN:
1461752
Hom.:
28
Cov.:
95
AF XY:
0.00447
AC XY:
3253
AN XY:
727170
show subpopulations
Gnomad4 AFR exome
AF:
0.000777
Gnomad4 AMR exome
AF:
0.00512
Gnomad4 ASJ exome
AF:
0.0134
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000823
Gnomad4 FIN exome
AF:
0.000807
Gnomad4 NFE exome
AF:
0.00493
Gnomad4 OTH exome
AF:
0.00556
GnomAD4 genome
AF:
0.00400
AC:
609
AN:
152324
Hom.:
2
Cov.:
33
AF XY:
0.00388
AC XY:
289
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00135
Gnomad4 AMR
AF:
0.00811
Gnomad4 ASJ
AF:
0.0138
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.000941
Gnomad4 NFE
AF:
0.00517
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00476
Hom.:
1
Bravo
AF:
0.00439
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00465
AC:
40
ExAC
AF:
0.00362
AC:
440
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00611
EpiControl
AF:
0.00510

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 22, 2015This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 30, 2013- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoSep 30, 2015- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2024RAI1: BP4, BS1, BS2 -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 06, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Smith-Magenis syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 05, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Uncertain
23
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.094
T;.;.
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.87
D;D;D
MetaRNN
Benign
0.0079
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
2.0
M;.;.
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.3
N;D;.
REVEL
Benign
0.19
Sift
Uncertain
0.0020
D;D;.
Sift4G
Uncertain
0.057
T;T;.
Polyphen
0.98
D;.;.
Vest4
0.51
MVP
0.12
MPC
0.35
ClinPred
0.027
T
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113208290; hg19: chr17-17697404; API